Dr. K. Hellinckx
Timeline
29 events since 2011Board
Filings
Financial
Permits
Establishments
20122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · on the deadline day
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0833412914
Annual accounts 2024 filed PDFabbreviated format · 21 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 22 days before the deadline
2023
Environmental permit granted Nieuwe publiciteitsinrichting (met inbegrip van vernieuwen van een bestaande vergunning) · Bonheiden
New establishment in Bonheiden Bona Derma, Mechelsesteenweg 136
Annual accounts 2022 filed PDFmicro format · 7 days before the deadline
2022
Highest result from 2011 to 2025 net €235,832 ▲31.1% The operating result of €295,605 and the net result of €235,832 are both a record.
Equity above €500,000 equity €532,415 ▲41.3% After 11 profitable years in a row, equity reaches €532,415.
Annual accounts 2021 filed PDFmicro format · 23 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 25 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 22 days before the deadline
Change of role: , from statutory manager to statutory director“1. De uitoefening van de volledige medische activiteit als dermatoloog, in naam en voor rekening van de…” (deed in Dutch) · Director discharge: · General meeting of 05-03-20206 points ▸
- General meeting, 05-03-2020
- 3,530 shares
- Director appointment, (statutory director), mentioned twice in the deed
- Registered office clause, Kerkenbos 21, 2812 Muizen (Mechelen)
- Director resignation, (statutory manager)
- Director discharge,
- The deed holds 8 more points.
2019
Annual accounts 2018 filed PDFmicro format · 20 days before the deadline
2018
Annual accounts 2017 filed PDFmicro format · 17 days late
2017
Annual accounts 2016 filed PDFmicro format · 34 days before the deadline
2016
Liquidity more than doubled current ratio 2.06 The current ratio rises from 0.86 to 2.06. Short-term debt falls from €121,659 to €98,778.
Annual accounts 2015 filed PDFabbreviated format · 2 days before the deadline
2015
Equity above €200,000 equity €221,270 ▲36.5% After 4 profitable years in a row, equity reaches €221,270.
Annual accounts 2014 filed PDFabbreviated format · 28 days before the deadline
First establishment Dermatologie Muizen, Kerkenbos 21, Mechelen
2014
Equity above €150,000 equity €162,114 ▲14.8% After 3 profitable years in a row, equity reaches €162,114.
Annual accounts 2013 filed PDFabbreviated format · 7 days before the deadline
2013
Liquidity more than 8 times current ratio 1.29 The current ratio rises from 0.16 to 1.29. Short-term debt falls from €118,894 to €87,567.
Equity above €100,000 equity €141,206 ▲357% After 2 profitable years in a row, equity reaches €141,206.
Annual accounts 2012 filed PDFabbreviated format · 22 days before the deadline
2012
Back to profit net €9,385 The net result is €9,385, after one loss-making year.
Annual accounts 2011 filed PDFabbreviated format · 47 days before the deadline
2011
Incorporation PDFpublished on 15-02-2011
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank